Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/1997
01/14/1997US5594116 Inoculating an avian; isolating immunoglobulins; binding to affinity matrix; elution
01/14/1997US5594114 Schwann cell mitogenic factor, its preparation and use
01/14/1997US5594108 Schizophrenia
01/14/1997US5594105 Peptide inhibitors of mitogenesis and motogenesis
01/14/1997US5594101 Anti-obesity proteins
01/14/1997US5593960 Producing cyclomarin a from fermentation of streptomyces
01/14/1997US5593884 Oncoprotein protein kinase
01/14/1997US5593882 Selectin variants
01/14/1997US5593881 Bacillus thuringiensis delta-endotoxin
01/14/1997US5593877 Nucleic acid and recombinant production of vespid venom hyaluronidase
01/14/1997US5593874 Dna for transgenic monocot plants and dna sequences
01/14/1997US5593864 Process for functional expression of the para cation channel
01/14/1997US5593858 Culturing host/vector pair where the host is selected from kluyveromyces
01/14/1997US5593856 Method for producing protein in a cell-free system
01/14/1997US5593825 Hepatitis B virus mutants, reagents and methods for detection
01/14/1997US5593822 IgG depleted serum preparations and methods for antibody production
01/14/1997CA2020062C Antibiotic agent
01/14/1997CA1338848C Hydrogenated derivatives of antibiotic a/16686
01/14/1997CA1338841C Monoclonal antibodies specific for human fibrinopeptide a
01/09/1997WO1997000959A1 Antigen non-specific glycosylation inhibiting factor derivatives
01/09/1997WO1997000955A1 Human homolog of the mouse rab18 gene
01/09/1997WO1997000952A2 A human edg-2 receptor homolog
01/09/1997WO1997000950A1 New immunoregulatory protein lst-1
01/09/1997WO1997000946A1 Immortalized epithelial tumor cell
01/09/1997WO1997000892A2 Depigmenting activity of agouti signal protein and peptides thereof
01/09/1997WO1997000888A1 Methods for reducing background binding in antibody preparations
01/09/1997WO1997000886A1 Obesity protein intermediates and their preparation and use
01/09/1997WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor
01/09/1997WO1996040040A3 Thrombin receptor homolog
01/09/1997WO1996039511A3 A c5a-like seven transmembrane receptor
01/09/1997WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
01/09/1997WO1996034088A3 Control of floral induction in plants and uses therefor
01/09/1997CA2225517A1 Haemopoietic growth factor antagonists and uses therefor
01/09/1997CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives
01/09/1997CA2224867A1 Obesity protein intermediates and their preparation and use
01/09/1997CA2224799A1 A human edg-2 receptor homolog
01/09/1997CA2224797A1 Immortalized epithelial tumor cell
01/09/1997CA2224691A1 Depigmenting activity of agouti signal protein and peptides thereof
01/09/1997CA2224687A1 Methods for reducing background binding in antibody preparations
01/09/1997CA2224247A1 Human homolog of the mouse rab18 gene
01/08/1997EP0752473A2 Cloning and characterization of H. pylori flbA gene: production of flagella-free strains
01/08/1997EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
01/08/1997EP0752102A1 Immunoenzymatic conjugate, preparation method therefor and uses thereof
01/08/1997EP0752008A1 Dna mutagenesis by random fragmentation and reassembly
01/08/1997EP0751998A1 A gene expression system utilizing an rna polymerase prebound to dna
01/08/1997EP0751992A1 Vascular endothelial growth factor 2
01/08/1997EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation
01/08/1997EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes
01/08/1997EP0751955A1 Super proteins including interferons and interleukins
01/08/1997EP0751784A1 Thyroxin-binding proteins
01/08/1997EP0751782A1 Methods for altering fertility
01/08/1997EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40
01/08/1997EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
01/08/1997EP0580672B1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
01/08/1997EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
01/08/1997EP0473724B1 A human cytokine, interleukin-9
01/08/1997EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES
01/08/1997EP0341273B1 Biological materials, processes for producing biological materials and for using such materials in therapy
01/08/1997EP0273928B1 A PROTEIN ACTIVE IN HUMORAL HYPERCALCEMIA OF MALIGNANCY-PTHrP
01/08/1997EP0268636B1 Polynucleotide sequences encoding the human FC RECEPTOR FOR IMMUNOGLOBULIN
01/08/1997CN1139955A Human kunitz-type protease inhibitors
01/08/1997CN1139933A Interleukin-6 (iL-6) antagonists
01/08/1997CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof
01/08/1997CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell
01/08/1997CN1139577A Usage of Barch mycin used as animal growth-promoting agent and its combination
01/08/1997CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it
01/08/1997CN1033759C 猪生长激素类似物 Porcine growth hormone analog
01/07/1997US5591828 Genetic engineering
01/07/1997US5591827 Interleukin-6 receptor antagonists
01/07/1997US5591823 Expression of specific immunogens using viral antigens
01/07/1997US5591718 Neutrophil activating factors
01/07/1997US5591648 Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them
01/07/1997US5591641 Nucleic acid encoding the growth hormone releasing hormone receptor
01/07/1997US5591640 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for preparing hirudin, hirudin obtained and its pharmaceutical use
01/07/1997US5591639 Plasmids and gene expression for dna sequences
01/07/1997US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI)
01/07/1997US5591629 Monoclonal antibodies which promote central nervous system remyelination
01/07/1997US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity
01/07/1997US5591614 Process for the enzymatic preparation of macrolactone
01/07/1997US5591604 Recombinant antibodies at the surface of E. coli
01/07/1997US5591602 Nucleic acid encoding opioid receptor
01/07/1997US5591601 DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system
01/07/1997US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor
01/07/1997US5591592 Method for detection of fibronectin receptor ligands
01/07/1997US5591583 Human restrictin and nucleic acid sequences
01/07/1997US5591574 Probes, diagnostic method and immunization method based on papillomavirus types HPV 49 and HPV 50
01/07/1997US5591572 Aids, hiv
01/07/1997US5591440 Hepatitis B Virus mutants, reagents and methods for detection
01/07/1997US5591432 Antibody to the neural cell adhesion molecule and methods of use
01/07/1997CA2079585C Ligand for the neu gene product
01/07/1997CA1338828C Bispecific antibody determinants
01/03/1997WO1997000445A1 Process for producing gm2 specific antibodies
01/03/1997WO1997000328A1 Modified porphyroproteins
01/03/1997WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use
01/03/1997WO1997000271A1 Novel high affinity human antibodies to tumor antigens
01/03/1997WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same
01/03/1997WO1996037621A3 Multimeric proteins
01/03/1997CA2245835A1 Novel high affinity human antibodies to tumor antigens
01/03/1997CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same
01/03/1997CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use